{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:41:47Z","timestamp":1767706907847,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30031-3","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:20Z","timestamp":1766898200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The prevalence and predictors of non-alcoholic fatty liver disease in Chinese patients with inflammatory bowel disease: a multicenter retrospective study"],"prefix":"10.1038","volume":"16","author":[{"given":"Yonghua","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijue","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"key":"30031_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"30031_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. Non-alcoholic fatty liver disease - A global public health perspective. J. Hepatol. 70, 531\u2013544 (2019).","journal-title":"J. Hepatol."},{"key":"30031_CR3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"TD Huang","year":"2020","unstructured":"Huang, T. D., Behary, J. & Zekry, A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern. Med. J. 50, 1038\u20131047 (2020).","journal-title":"Intern. Med. J."},{"key":"30031_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739\u2013752 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"30031_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/ibd\/izaa189","volume":"27","author":"A Lin","year":"2021","unstructured":"Lin, A., Roth, H., Anyane-Yeboa, A., Rubin, D. T. & Paul, S. Prevalence of nonalcoholic fatty liver disease in patients with inflammatory bowel disease: A systematic review and Meta-analysis. Inflamm. Bowel Dis. 27, 947\u2013955 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"30031_CR6","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/MIB.0000000000000832","volume":"22","author":"T Bessissow","year":"2016","unstructured":"Bessissow, T. et al. Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 22, 1937\u20131944 (2016).","journal-title":"Inflamm. Bowel Dis."},{"key":"30031_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-017-0124-2","volume":"9","author":"A Sartini","year":"2018","unstructured":"Sartini, A. et al. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. Cell. Death Dis. 9, 87 (2018).","journal-title":"Cell. Death Dis."},{"key":"30031_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/cld.1046","volume":"17","author":"P Patel","year":"2021","unstructured":"Patel, P. & Dalal, S. Hepatic manifestations of inflammatory bowel disease. Clin. Liver Dis. (Hoboken). 17, 292\u2013296 (2021).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"30031_CR9","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3109\/00365521.2014.921326","volume":"49","author":"DL Nguyen","year":"2014","unstructured":"Nguyen, D. L., Bechtold, M. L. & Jamal, M. M. National trends and inpatient outcomes of inflammatory bowel disease patients with concomitant chronic liver disease. Scand. J. Gastroenterol. 49, 1091\u20131095 (2014).","journal-title":"Scand. J. Gastroenterol."},{"key":"30031_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.giec.2020.12.004","volume":"31","author":"JD McCain","year":"2021","unstructured":"McCain, J. D., Pasha, S. F. & Leighton, J. A. Role of capsule endoscopy in inflammatory bowel disease. Gastrointest. Endosc Clin. N Am. 31, 345\u2013361 (2021).","journal-title":"Gastrointest. Endosc Clin. N Am."},{"key":"30031_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4093\/dmj.2011.35.6.561","volume":"35","author":"SW Oh","year":"2011","unstructured":"Oh, S. W. Obesity and metabolic syndrome in Korea. Diabetes Metab. J. 35, 561\u2013566 (2011).","journal-title":"Diabetes Metab. J."},{"key":"30031_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","volume":"11","author":"P Gionchetti","year":"2017","unstructured":"Gionchetti, P. et al. 3rd European Evidence-based consensus on the diagnosis and management of crohn\u2019s disease 2016: part 2: surgical management and special situations. J. Crohns Colitis. 11, 135\u2013149 (2017).","journal-title":"J. Crohns Colitis"},{"key":"30031_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro, F. et al. Third European Evidence-based consensus on diagnosis and management of ulcerative Colitis. Part 1: Definitions, diagnosis, Extra-intestinal Manifestations, Pregnancy, cancer Surveillance, Surgery, and Ileo-anal pouch disorders. J. Crohns Colitis. 11, 649\u2013670 (2017).","journal-title":"J. Crohns Colitis"},{"key":"30031_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best, W. R., Becktel, J. M., Singleton, J. W. & Kern, F. Jr. Development of a crohn\u2019s disease activity index. National cooperative crohn\u2019s disease study. Gastroenterology 70, 439\u2013444 (1976).","journal-title":"Gastroenterology"},{"key":"30031_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder, K. W., Tremaine, W. J. & Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl. J. Med. 317, 1625\u20131629 (1987).","journal-title":"N Engl. J. Med."},{"key":"30031_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","volume":"132","author":"G D\u2019Haens","year":"2007","unstructured":"D\u2019Haens, G. et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132, 763\u2013786 (2007).","journal-title":"Gastroenterology"},{"key":"30031_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi, J., Silverberg, M. S., Vermeire, S. & Colombel, J. F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55, 749\u2013753 (2006).","journal-title":"Gut"},{"key":"30031_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n, F. et al. 3rd European Evidence-based consensus on the diagnosis and management of crohn\u2019s disease 2016: part 1: diagnosis and medical management. J. Crohns Colitis. 11, 3\u201325 (2017).","journal-title":"J. Crohns Colitis"},{"key":"30031_CR19","doi-asserted-by":"publisher","first-page":"W168","DOI":"10.2214\/AJR.16.16726","volume":"208","author":"JS Paige","year":"2017","unstructured":"Paige, J. S. et al. A pilot comparative study of quantitative Ultrasound, conventional Ultrasound, and MRI for predicting Histology-Determined steatosis grade in adult nonalcoholic fatty liver disease. AJR Am. J. Roentgenol. 208, W168\u2013W177 (2017).","journal-title":"AJR Am. J. Roentgenol."},{"key":"30031_CR20","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/j.crohns.2012.10.015","volume":"7","author":"A Sourianarayanane","year":"2013","unstructured":"Sourianarayanane, A. et al. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. J. Crohns Colitis. 7, e279\u2013e285 (2013).","journal-title":"J. Crohns Colitis"},{"key":"30031_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.humpath.2017.09.008","volume":"69","author":"DE Bosch","year":"2017","unstructured":"Bosch, D. E. & Yeh, M. M. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease. Hum. Pathol. 69, 55\u201362 (2017).","journal-title":"Hum. Pathol."},{"key":"30031_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00004836-200305000-00012","volume":"36","author":"S Bargiggia","year":"2003","unstructured":"Bargiggia, S. et al. Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J. Clin. Gastroenterol. 36, 417\u2013420 (2003).","journal-title":"J. Clin. Gastroenterol."},{"key":"30031_CR23","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s10620-017-4495-0","volume":"62","author":"RM Carr","year":"2017","unstructured":"Carr, R. M. et al. Intestinal inflammation does not predict nonalcoholic fatty liver disease severity in inflammatory bowel disease patients. Dig. Dis. Sci. 62, 1354\u20131361 (2017).","journal-title":"Dig. Dis. Sci."},{"key":"30031_CR24","first-page":"283","volume":"32","author":"A Likhitsup","year":"2019","unstructured":"Likhitsup, A. et al. Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department. Ann. Gastroenterol. 32, 283\u2013286 (2019).","journal-title":"Ann. Gastroenterol."},{"key":"30031_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez, R. et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54, 1082\u20131090 (2011).","journal-title":"Hepatology"},{"key":"30031_CR26","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/jcm14092973","volume":"14","author":"L Abenavoli","year":"2025","unstructured":"Abenavoli, L. et al. Use of metabolic scores and lipid ratios to predict metabolic Dysfunction-Associated steatotic liver disease onset in patients with inflammatory bowel diseases. J. Clin. Med. 14, 2973 (2025).","journal-title":"J. Clin. Med."},{"key":"30031_CR27","doi-asserted-by":"publisher","first-page":"e0180036","DOI":"10.1371\/journal.pone.0180036","volume":"12","author":"S Bamba","year":"2017","unstructured":"Bamba, S. et al. Sarcopenia is a predictive factor for intestinal resection in admitted patients with crohn\u2019s disease. PLoS One. 12, e0180036 (2017).","journal-title":"PLoS One"},{"key":"30031_CR28","doi-asserted-by":"publisher","first-page":"e004876","DOI":"10.1161\/JAHA.116.004876","volume":"6","author":"YL Cheng","year":"2017","unstructured":"Cheng, Y. L. et al. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. J. Am. Heart Assoc. 6, e004876 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"30031_CR29","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/nu13082772","volume":"13","author":"G Gibiino","year":"2021","unstructured":"Gibiino, G. et al. The other side of malnutrition in inflammatory bowel disease (IBD): Non-Alcoholic fatty liver disease. Nutrients 13, 2772 (2021).","journal-title":"Nutrients"},{"key":"30031_CR30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ecco-jcc\/jjy095","volume":"12","author":"KC Cushing","year":"2018","unstructured":"Cushing, K. C., Kordbacheh, H., Gee, M. S., Kambadakone, A. & Ananthakrishnan, A. N. Sarcopenia is a novel predictor of the need for rescue therapy in hospitalized ulcerative colitis patients. J. Crohns Colitis. 12, 1036\u20131041 (2018).","journal-title":"J. Crohns Colitis"},{"key":"30031_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejim.2023.10.019","volume":"120","author":"SJ Mart\u00ednez-Dom\u00ednguez","year":"2024","unstructured":"Mart\u00ednez-Dom\u00ednguez, S. J. et al. Crohn\u00b4s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease. Eur. J. Intern. Med. 120, 99\u2013106 (2024).","journal-title":"Eur. J. Intern. Med."},{"key":"30031_CR32","first-page":"463","volume":"32","author":"A Likhitsup","year":"2019","unstructured":"Likhitsup, A. et al. High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy. Ann. Gastroenterol. 32, 463\u2013468 (2019).","journal-title":"Ann. Gastroenterol."},{"key":"30031_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C. & Smith, A. D. Liver biopsy. Hepatology 49, 1017\u20131044 (2009).","journal-title":"Hepatology"},{"key":"30031_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1055\/s-0028-1091983","volume":"28","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska, A. & Feldstein, A. E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis. 28, 386\u2013395 (2008).","journal-title":"Semin Liver Dis."},{"key":"30031_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1148\/rg.266065004","volume":"26","author":"OW Hamer","year":"2006","unstructured":"Hamer, O. W. et al. Fatty liver: imaging patterns and pitfalls. Radiographics 26, 1637\u20131653 (2006).","journal-title":"Radiographics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30031-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:38:37Z","timestamp":1767706717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30031-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30031"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30031-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,12,28]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"515"}}